The third Learning Collaborative discussion took place on January 21. The goal of this call was to discuss the options for financing RSV vaccine in birthing centers from research conducted by the Camden Coalition. This ongoing collaboration aims to increase the capacity of jurisdictions to equitably protect infants from serious illness and death due to RSV. Through understanding the challenges to birthing hospital participation in the Vaccines for Children (VFC) program and sharing promising practices, the collaborative hopes to increase birthing hospital participation in the VFC program and help to ensure that every newborn has the opportunity to be protected from RSV disease.
Learning Collaborative Call January 21, 2025
Related Resources
Unpacking the 2025 AIM Annual Survey: Trends, Challenges, and What’s Ahead Webinar
On April 14, 2026, AIM hosted a data-focused webinar, Unpacking the 2025 AIM Annual Survey: Trends, Challenges, and What’s Ahead.
2025-2026 Respiratory Syncytial Virus (RSV) Monoclonal Antibody (mAb) Season Extension Map
The AIM RSV Season Extension Map provides a national snapshot of how the 66 federally funded immunization programs are responding to recent increases in RSV cases.
Learning Collaborative Call March 12, 2026
The fifth session of the Birthing Hospitals and VFC: A Learning Collaborative to Protect Infants from RSV, was held on March 12, 2026.
